Impact of molecular residual disease post allografting in myelofibrosis patients
Wolschke, C, Badbaran, A, Zabelina, T, Christopeit, M, Ayuk, F, Triviai, I, Zander, A, Alchalby, H, Bacher, U, Fehse, B, Kröger, N
Published in Bone marrow transplantation (Basingstoke) (01.11.2017)
Published in Bone marrow transplantation (Basingstoke) (01.11.2017)
Get full text
Journal Article
Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective
Ahmadi, P, Ghandili, S, Jakobs, F, Konnopka, C, Morgner-Miehlke, A, Kröger, N, Ayuk, F
Published in Bone marrow transplantation (Basingstoke) (01.04.2024)
Published in Bone marrow transplantation (Basingstoke) (01.04.2024)
Get full text
Journal Article
JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis
Stübig, T, Alchalby, H, Ditschkowski, M, Wolf, D, Wulf, G, Zabelina, T, Wolschke, C, Ayuk, F, Kröger, N
Published in Leukemia (01.08.2014)
Published in Leukemia (01.08.2014)
Get full text
Journal Article
Donor choice according to age for allo-SCT for AML in complete remission
AYUK, F, ZABELINA, T, WORTMANN, F, ALCHALBY, H, WOLSCHKE, C, LELLEK, H, BACHER, U, ZANDER, A, KRÖGER, N
Published in Bone marrow transplantation (Basingstoke) (01.08.2013)
Published in Bone marrow transplantation (Basingstoke) (01.08.2013)
Get full text
Journal Article
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
KRÖGER, N, ZABELINA, T, BACHER, U, BADBARAN, A, SCHILLING, G, HANSEN, T, ATANACKOVIC, D, ZANDER, A. R, KLYUCHNIKOV, E, KROPFF, M, PFLÜGER, K.-H, BURCHERT, A, STÜBIG, T, WOLSCHKE, C, AYUK, F, HILDEBRANDT, Y
Published in Bone marrow transplantation (Basingstoke) (01.03.2013)
Published in Bone marrow transplantation (Basingstoke) (01.03.2013)
Get full text
Journal Article
Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
Badbaran, A, Fehse, B, Christopeit, M, Aranyossy, T, Ayuk, F A, Wolschke, C, Kröger, N
Published in Bone marrow transplantation (Basingstoke) (01.06.2016)
Published in Bone marrow transplantation (Basingstoke) (01.06.2016)
Get full text
Journal Article
Axicabtagene ciloleucel (Axicel) for relapsed/refractory primary mediastinal B‐cell lymphoma (r/r PMBCL) compared to DLBCL‐NOS: A GLA/DRST registry study
Schubert, M., Ayuk, F. A., Bethge, W., Bonin, M., Vucinic, V., Wagner‐Drouet, E. M., Subklewe, M., Baldus, C. D., Glass, B., Marks, R., Mougiakakos, D., Schroers, R., Stelljes, M., Topp, M. S., Wulf, G., Kröger, N., Dreger, P.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
Christopeit, M, Badbaran, A, Zabelina, T, Zeck, G, Fehse, B, Ayuk, F, Wolschke, C, Kröger, N
Published in Bone marrow transplantation (Basingstoke) (01.10.2016)
Published in Bone marrow transplantation (Basingstoke) (01.10.2016)
Get full text
Journal Article
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells
LIOZNOV, M, EL-CHEIKH, J, FEHSE, B, ZANDER, A. R, BLAISE, D, MOHTY, M, KRÖGER, N, HOFFMANN, F, HILDEBRANDT, Y, AYUK, F, WOLSCHKE, C, ATANACKOVIC, D, SCHILLING, G, BADBARAN, A, BACHER, U
Published in Bone marrow transplantation (Basingstoke) (01.02.2010)
Published in Bone marrow transplantation (Basingstoke) (01.02.2010)
Get full text
Journal Article
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT
OCHENI, S, KROEGER, N, KABISCH, H, ZANDER, A. R, BACHER, U, ZABELINA, T, SOBOTTKA, I, AYUK, F, WOLSCHKE, C, MUTH, A, LELLEK, H, PETERSEN, L, ERTTMANN, R
Published in Bone marrow transplantation (Basingstoke) (01.08.2008)
Published in Bone marrow transplantation (Basingstoke) (01.08.2008)
Get full text
Journal Article
Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
WOLSCHKE, C, ZABELINA, T, WORTMANN, F, LELLEK, H, RANDENBORGH, A, ZANDER, A, KRÖGER, N, AYUK, F, ALCHALBY, H, BERGER, J, KLYUCHNIKOV, E, PEIN, U.-M, SCHUMACHER, S, AMTSFELD, G, ADJALLE, R
Published in Bone marrow transplantation (Basingstoke) (01.01.2014)
Published in Bone marrow transplantation (Basingstoke) (01.01.2014)
Get full text
Journal Article
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
SCHILLING, G, HANSEN, T, OTTERSTETTER, S, PENAS, E. M. M, DIERLAMM, J, AYUK, F, ATANACKOVIC, D, BACHER, U, BOKEMEYER, C, ZANDER, A, MIGUEL, J. S, NAGLER, A, SHIMONI, A, KRÖGER, N, ZABELINA, T, SIMON-PEREZ, J.-A, GUTIERREZ, N. C, BETHGE, W, LIEBISCH, P, SCHWERDTFEGER, R, BORNHÄUSER, M
Published in Leukemia (01.06.2008)
Published in Leukemia (01.06.2008)
Get full text
Journal Article
CAR‐HEMATOTOX: A DISCRIMINATIVE MODEL FOR CAR T‐CELL RELATED HEMATOTOXICITY IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA
Rejeski, K., Perez, A., Sesques, P., Berger, C., Jentzsch, L., Mougiakakos, D., Frölich, L., Ackermann, J., Bücklein, V., Blumenberg, V., Schmidt, C., Jallades, L., Fehse, B., Faul, C., Karschnia, P., Weigert, O., Dreyling, M., Hoster, E., Locke, F., von Bergwelt‐Baildon, M., Mackensen, A., Bethge, W., Ayuk, F., Bachy, E., Salles, G., Jain, M., Subklewe, M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS
Dreger, P., Martus, P., Holtick, U., Ayuk, F., Wagner‐Drouet, E. M., Wulf, G., Marks, R., Penack, O., Koenecke, C., von Bonin, M., von Tresckow, B., Stelljes, M., Baldus, C., Vucinic, V., Mougiakakos, D., Topp, M., Wolff, D., Schroers, R., Schmitt, M., Schmitt, T., Lengerke, C., Thomas, S., Beelen, D. W., Bethge, W.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Suspected encephalitis with Candida tropicalis and Fusarium detected by unbiased RNA sequencing
Christopeit, M., Grundhoff, A., Rohde, H., Belmar-Campos, C., Grzyska, U., Fiehler, J., Wolschke, C., Ayuk, F., Kröger, N., Fischer, Nicole
Published in Annals of hematology (01.10.2016)
Published in Annals of hematology (01.10.2016)
Get full text
Journal Article
P1024: IMPACT OF TP53 IN MYELOFIBROSIS UNDERGOING STEM CELL TRANSPLANTATION
Gagelmann, N., Badbaran, A., Panagiota, V., Wolschke, C., Ayuk, F., Thol, F., Ditschkowski, M., Cassinat, B., Robin, M., Schroeder, T., Heuser, M., Reinhardt, H. C., Kröger, N.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1184: PHASE I TRIAL OF MB‐CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B‐CELL NON‐HODGKIN LYMPHOMA: 2 YEAR FOLLOW‐UP REPORT
Borchmann, P., Lohneis, A., Gödel, P., Balke‐Want, H., Schmid, C., Ayuk, F., Holtkamp, S., Hanssens, L., Zadoyan, G., Friedrichs, B., Assenmacher, M., Bürger, I., Schneider, D., Overstijns, T., Scheid, C., Holtick, U., Miltenyi, S., Hallek, M.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1448: LONG‐TERM SURVIVORS AFTER FAILURE OF CAR‐T CELL THERAPY FOR R/R LARGE B‐CELL LYMPHOMA (LBCL): A GLA/DRST STUDY
Derigs, P., Bethge, W., Holtick, U., Tresckow, B., Ayuk, F., Penack, O., Vucinic, V., Bonin, M., Baldus, C., Mougiakakos, D., Wulf, G., Schnetzke, U., Stelljes, M., Thomas, S., Schroers, R., Kroeger, N., Dreger, P.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)
Kröger, N, Bornhäuser, M, Stelljes, M, Pichlmeier, U, Trenschel, R, Schmid, C, Arnold, R, Martin, H, Heinzelmann, M, Wolschke, C, Meyer, R G, Bethge, W, Kobbe, G, Ayuk, F, Gökbuget, N, Hölzer, D, Zander, A, Beelen, D
Published in Bone marrow transplantation (Basingstoke) (01.12.2015)
Published in Bone marrow transplantation (Basingstoke) (01.12.2015)
Get full text
Journal Article